Economic evaluation of laboratory diagnostic test types in Covid-19 epidemic: A systematic review
Authors:
- 17 August 2022
- journal article
- review article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 105, 106820
Abstract
Corona 2 virus (SARS-CoV-2) is known as the causative agent of COVID-19 disease; the World Health Organization (WHO) declared it an epidemic on March 11, 2020. The Joint Guidelines of the Centers for Disease Control and Prevention (CDC) and the WHO including social distancing, the use of face masks, emphasis on hand washing, quarantine, and using diagnosis tests have been used widely, but the value of diagnostic interventions to prevent the transmission of SARS-CoV-2 is unclear. We compared the economic evaluation of different laboratory diagnostic interventions with each other and also with implementing the conservative CDC & WHO guidelines. Electronic searches were conducted on PubMed, Embase, Science Direct, Scopus, Cochrane Library, Web of Knowledge, NHSEED, NHS Health Technology assessment (CRD), and Cost-Effectiveness Analysis Registry databases. Related articles were reviewed from January 2020 to the end of November 2021. Out of 1791 initial studies, 13 articles had the inclusion criteria. According to the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist, ten studies were of excellent quality, and the remaining two studies were of very good quality. Most studies were cost-effectiveness analysis studies. The entered studies had different time horizons. Diagnostic tests reviewed in the studies included real-time polymerase chain reaction (RT-PCR) test, immunoglobulin G (IgG) & Antigen, point of care tests. Although polymerase chain reaction (PCR) testing improves the quality of life and survival for patients with infected Covid-19 based on its greater effectiveness compared to standard protection protocols, due to the high cost of this intervention, it has been considered a cost-effective method in some countries. Since most studies have been conducted in developed countries, it unquestionably does not make sense to extend these results to low-income and developing countries. Therefore further studies are required in low-income and developing countries to evaluate the cost-effectiveness of laboratory-based diagnostic methods (RT-PCR) of covid-19 in variable prevalence of infectious cases.Keywords
Funding Information
- Ilam University of Medical Sciences (IR.MEDILAM.REC.1400.056)
This publication has 34 references indexed in Scilit:
- World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)International Journal of Surgery, 2020
- Preparedness and vulnerability of African countries against importations of COVID-19: a modelling studyThe Lancet, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or bothBMJ, 2017
- Rapid Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2017
- Comparing nonpharmaceutical interventions for containing emerging epidemicsProceedings of the National Academy of Sciences, 2017
- Strengthening the Detection of and Early Response to Public Health Emergencies: Lessons from the West African Ebola EpidemicPLOS Medicine, 2015
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task ForceValue in Health, 2013
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementCost Effectiveness and Resource Allocation, 2013
- Social Mixing Patterns Within a South African Township Community: Implications for Respiratory Disease Transmission and ControlAmerican Journal of Epidemiology, 2011